Publications & Resources

The U.S. Food and Drug Administration has approved the antiviral drug remdesivir, sold as Veklury, to treat COVID-19 patients who meet specific criteria.

Based on a series of patient testimonials, the National Institute for Health Research says that ‘long COVID’ could actually be up to four different syndromes.

As use of telehealth continues to grow, physicians are advised to consider key factors when determining whether a virtual visit is the best option for a patient.

As telehealth use continues to rise, physicians are strongly encouraged to adopt practices that can help reduce the risk of an associated medical malpractice claim.

New York State legislation now requires physicians’ offices to post signage directing patients to the Office of Professional Medical Conduct’s website for information on reporting misconduct.

Patient satisfaction is an integral part of providing healthcare, regardless of the clinical setting. All physician office practices should have a policy or protocol in place to address patient complaints. Review this Risk Management Tip from MLMIC to reinforce related policies and protocols within your practice or facility.

Join MLMIC and HANYS on Tuesday, October 27, at noon for a complimentary webinar on common risks of evolving healthcare technologies and strategies for safely managing their implementation and use.

A new prediction model, called the COVID Inpatient Risk Calculator, can help forecast if a patient is at high risk of developing severe COVID-19 or dying from the virus.

An update to New York State Executive Order 202.61 says healthcare personnel who order and administer COVID-19 tests must now document and report if the patient attends, works or volunteers in a school.

MLMIC encourages policyholders to review attorneys’ answers to frequently asked questions on medical professional liability related to informed consent, including legal guidance on who’s responsible for obtaining it and which situations require it.